FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2607412849> ?p ?o ?g. }

• W2607412849 endingPage "31" @default.
• W2607412849 startingPage "25" @default.
• W2607412849 abstract "Chronic constipation is a highly common functional gastrointestinal disorder that adversely affects patient quality of life. At present, limited therapeutic options are available for the treatment of chronic constipation, which indicates the need for new therapeutic agents. Herein, we report the potential of mizagliflozin, a novel selective sodium glucose co-transporter 1 (SGLT1) inhibitor, for the amelioration of chronic constipation. Mizagliflozin's inhibitory activity against SGLTs was evaluated by an in vitro assay of cells transiently expressing SGLTs. The safety profile of an initial single dose (2–160 mg, orally) and multiple doses (2–20 mg, orally, once daily immediately prior to breakfast on Days 1 and 13, and three times daily immediately prior to every meal on Days 3–12) of mizagliflozin was determined by performing a phase I study in healthy male subjects. In addition, the effect of mizagliflozin and lubiprostone on fecal wet weight was compared using a dog model of loperamide-induced constipation and rat model of low-fiber-diet-induced constipation. Mizagliflozin potently inhibited human SGLT1 in a highly selective manner. The results of the phase I study showed mizagliflozin increased stool frequency and loosened stool consistency; these effects increased progressively with an increase in the dosage and the number of doses of mizagliflozin. In addition, the oral administration of mizagliflozin increased fecal wet weight in a dog model of loperamide-induced constipation and a rat model of low-fiber-diet-induced constipation, similar to lubiprostone. These results suggest the potential use of a novel selective SGLT1 inhibitor, mizagliflozin, for the amelioration of chronic constipation." @default.
• W2607412849 created "2017-04-28" @default.
• W2607412849 creator A5006884501 @default.
• W2607412849 creator A5014349993 @default.
• W2607412849 creator A5022995739 @default.
• W2607412849 creator A5027342755 @default.
• W2607412849 creator A5035626968 @default.
• W2607412849 creator A5045000792 @default.
• W2607412849 creator A5049942879 @default.
• W2607412849 creator A5052382093 @default.
• W2607412849 creator A5063530621 @default.
• W2607412849 creator A5080828107 @default.
• W2607412849 creator A5084727295 @default.
• W2607412849 date "2017-07-01" @default.
• W2607412849 modified "2023-10-03" @default.
• W2607412849 title "Mizagliflozin, a novel selective SGLT1 inhibitor, exhibits potential in the amelioration of chronic constipation" @default.
• W2607412849 cites W1498318503 @default.
• W2607412849 cites W1524124291 @default.
• W2607412849 cites W1795105351 @default.
• W2607412849 cites W1921373566 @default.
• W2607412849 cites W1969979801 @default.
• W2607412849 cites W1973038508 @default.
• W2607412849 cites W1974115114 @default.
• W2607412849 cites W1978189564 @default.
• W2607412849 cites W1990568669 @default.
• W2607412849 cites W1995649974 @default.
• W2607412849 cites W1996852467 @default.
• W2607412849 cites W2004862250 @default.
• W2607412849 cites W2012800693 @default.
• W2607412849 cites W2013360592 @default.
• W2607412849 cites W2047515450 @default.
• W2607412849 cites W2050817101 @default.
• W2607412849 cites W2051728893 @default.
• W2607412849 cites W2052764225 @default.
• W2607412849 cites W2060622284 @default.
• W2607412849 cites W2064201279 @default.
• W2607412849 cites W2065273044 @default.
• W2607412849 cites W2077188216 @default.
• W2607412849 cites W2078792098 @default.
• W2607412849 cites W2082604296 @default.
• W2607412849 cites W2085139899 @default.
• W2607412849 cites W2086812198 @default.
• W2607412849 cites W2086860898 @default.
• W2607412849 cites W2090144284 @default.
• W2607412849 cites W2111008362 @default.
• W2607412849 cites W2112043952 @default.
• W2607412849 cites W2114567997 @default.
• W2607412849 cites W2131135469 @default.
• W2607412849 cites W2141228342 @default.
• W2607412849 cites W2143686535 @default.
• W2607412849 cites W2144173715 @default.
• W2607412849 cites W2148517939 @default.
• W2607412849 cites W2149185387 @default.
• W2607412849 cites W2153635840 @default.
• W2607412849 cites W2156370227 @default.
• W2607412849 cites W2157476765 @default.
• W2607412849 cites W2161996137 @default.
• W2607412849 cites W2164055731 @default.
• W2607412849 cites W2170276146 @default.
• W2607412849 cites W2304181019 @default.
• W2607412849 cites W2304389785 @default.
• W2607412849 cites W2611380183 @default.
• W2607412849 doi "https://doi.org/10.1016/j.ejphar.2017.04.010" @default.
• W2607412849 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28410751" @default.
• W2607412849 hasPublicationYear "2017" @default.
• W2607412849 type Work @default.
• W2607412849 sameAs 2607412849 @default.
• W2607412849 citedByCount "27" @default.
• W2607412849 countsByYear W26074128492018 @default.
• W2607412849 countsByYear W26074128492019 @default.
• W2607412849 countsByYear W26074128492020 @default.
• W2607412849 countsByYear W26074128492021 @default.
• W2607412849 countsByYear W26074128492022 @default.
• W2607412849 countsByYear W26074128492023 @default.
• W2607412849 crossrefType "journal-article" @default.
• W2607412849 hasAuthorship W2607412849A5006884501 @default.
• W2607412849 hasAuthorship W2607412849A5014349993 @default.
• W2607412849 hasAuthorship W2607412849A5022995739 @default.
• W2607412849 hasAuthorship W2607412849A5027342755 @default.
• W2607412849 hasAuthorship W2607412849A5035626968 @default.
• W2607412849 hasAuthorship W2607412849A5045000792 @default.
• W2607412849 hasAuthorship W2607412849A5049942879 @default.
• W2607412849 hasAuthorship W2607412849A5052382093 @default.
• W2607412849 hasAuthorship W2607412849A5063530621 @default.
• W2607412849 hasAuthorship W2607412849A5080828107 @default.
• W2607412849 hasAuthorship W2607412849A5084727295 @default.
• W2607412849 hasConcept C126322002 @default.
• W2607412849 hasConcept C2777056448 @default.
• W2607412849 hasConcept C2777573665 @default.
• W2607412849 hasConcept C2779802037 @default.
• W2607412849 hasConcept C2780661987 @default.
• W2607412849 hasConcept C2781093762 @default.
• W2607412849 hasConcept C2781112942 @default.
• W2607412849 hasConcept C3017955636 @default.
• W2607412849 hasConcept C71924100 @default.
• W2607412849 hasConcept C90924648 @default.
• W2607412849 hasConcept C98274493 @default.
• W2607412849 hasConceptScore W2607412849C126322002 @default.

• next